-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Vanda Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from 2013 to Q1 2025.
- Vanda Pharmaceuticals Inc. Depreciation for the quarter ending March 31, 2025 was $231K, a 12.1% increase year-over-year.
- Vanda Pharmaceuticals Inc. annual Depreciation for 2024 was $859K, a 6.63% decline from 2023.
- Vanda Pharmaceuticals Inc. annual Depreciation for 2023 was $920K, a 24.4% decline from 2022.
- Vanda Pharmaceuticals Inc. annual Depreciation for 2022 was $1.22M, a 10.7% decline from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)